# Safety and Tolerability of Autologous Non-hematopoietic Peripheral Blood Stem Cells Therapy in Healthy Adult Volunteers.

> **NCT04645485** · PHASE1 · COMPLETED · sponsor: **Abu Dhabi Stem Cells Center** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Nebulization of autologous non-hematopoietic peripheral blood stem cells (NHPBSC).

## Key facts

- **NCT ID:** NCT04645485
- **Lead sponsor:** Abu Dhabi Stem Cells Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-12
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-07-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04645485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04645485, "Safety and Tolerability of Autologous Non-hematopoietic Peripheral Blood Stem Cells Therapy in Healthy Adult Volunteers.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04645485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*